Clinical TrialsSearch results for "enfortumab"
Number of results: 8
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Not yet recruiting
- A study of ASP2998 given by itself and given with standard therapies in people with solid tumors
- Locally advanced or metastatic malignant solid tumors
- Gupta Anumeha
- 2026-02-17
Recruiting
- NCCH2412/MK015 Trial
- Small Bowel Adenocarcinoma
- Kato Ken
- 2025-10-09
No Longer Recruiting
- A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Metastatic Solid Tumor Recurrent Solid Tumor Advanced Solid Tumor
- Masaki Takeshi
- 2024-08-28
Recruiting
- A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
- Metastatic Solid Tumor Recurrent Solid Tumor Advanced Solid Tumor
- Masaki Takeshi
- 2024-05-14
Completed
- A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors
- * Neoplasms * Non-small-cell Lung Cancer * Urothelial Carcinoma * (and 5 more...)
- Kawai Norisuke
- 2024-03-28
Recruiting
- Phase 2 Study of HER3-DXd in Locally Advanced or Metastatic Solid Tumors
- Locally Advanced or Metastatic Solid Tumors
- Inoguchi Akihiro
- 2024-01-18
Recruiting
- A Study of Disitamab Vedotin Alone or with Pembrolizumab in Urothelial Cancer That Expresses HER2
- Urothelial carcinoma
- Kawai Norisuke
- 2023-08-28
Recruiting
- FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
- Urinary Bladder Neoplasms Neoplasm Metastasis Ureteral Neoplasms
- Masaki Takeshi
- 2023-05-26
- 1